EUVIMEDEUVIMED entdecken
Crossref

Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas

Naveen Premnath iD, Yulun Liu, Heather Reves iD, Urvashi Pandey, Rasmi G Nair iD, Julia Anderson iD, Aimaz Afrough iD, Larry D Anderson iD, Stephen S Chung, Gurbakhash Kaur iD, Adeel M Khan iD, Kiran A Kumar iD und 6 weitere

JCO Oncology Practice · 2025

DOI: 10.1200/op.24.00354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2025. Verfasst von Naveen Premnath und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Oncology and Transplantation, University of Minnesota, Masonic Cancer Center, Minneapolis, MN. Hauptthemen laut MEDLINE: Patient Protection and Affordable Care Act, Medicaid, HIV Infections, Lymphoma, B-Cell. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE To study the influence of the Affordable Care Act (ACA) policy and its Medicaid expansion on insurance status and survival in patients with HIV with aggressive lymphoma. METHODS We used the National Cancer Database, a hospital-based national registry, to identify adults age 18-64 years with HIV-associated aggressive B-cell non-Hodgkin lymphomas (HIV-a-B-NHLs), diagnosed during 2007 to 2016. Survival analysis was performed on a subset of patients with HIV-a-B-NHL for whom location data were available who resided in Medicaid expansion–adopted and nonadopted states. Using a quasi-experimental difference-in-difference model, the difference in adjusted 2-year survival rates obtained with a flexible parametric Weibull model was compared for states that adopted the Medicaid expansion of ACA against those that did not adopt the expansion. RESULTS We identified 8,231 patients with HIV-a-B-NHL and 50,650 non-HIV patients with a-B-NHL. We found that a lower proportion of individuals were uninsured at diagnosis in the expansion states compared with nonexpansion states. We also found that the ACA policy adoption led to a reduction in the proportion of uninsured individuals with HIV-a-B-NHL in expansion states of 34.9%, compared with 15.9% in non–expansion-adopted states. There was a statistically significant improvement in the 2-year survival rate among patients with HIV-a-B-NHL in the expansion compared with nonexpansion states with the adoption of ACA (7.17% v 1.58%, P = .02). CONCLUSION Using a novel quasi-experimental model, we found that the ACA policy corresponded with a greater survival improvement in patients with HIV-a-B-NHL within Medicaid expansion–adopted states compared with nonexpansion states. We believe that this evidence should be taken into consideration in future policy making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient Protection and Affordable Care ActMedicaidHIV InfectionsLymphoma, B-CellHumansUnited StatesAdultFemaleMaleMiddle AgedAdolescentYoung AdultInsurance Coverage

Autor:innen und Institutionen

  • Division of Hematology, Oncology and Transplantation, University of Minnesota, Masonic Cancer Center, Minneapolis, MN.
  • Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX.
  • Section of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
  • Department of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.

ORCID-Profile: Naveen Premnath, Heather Reves, Rasmi G Nair, Julia Anderson, Aimaz Afrough, Larry D Anderson, Gurbakhash Kaur, Adeel M Khan, Kiran A Kumar, Yazan F Madanat, Heather R Wolfe, Elif Yilmaz, Praveen Ramakrishnan Geethakumari

Zitieren

APA

Premnath, N., Liu, Y., Reves, H., Pandey, U., Nair, R. G., Anderson, J., Afrough, A., Anderson, L. D., Chung, S. S., Kaur, G., Khan, A. M., Kumar, K. A., Madanat, Y. F., Wolfe, H. R., Yilmaz, E., Awan, F. T., Sweetenham, J., & Ramakrishnan Geethakumari, P. (2025). Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas. JCO Oncology Practice. https://doi.org/10.1200/op.24.00354

Vancouver

Premnath N, Liu Y, Reves H, Pandey U, Nair RG, Anderson J, et al. Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas. JCO Oncology Practice. 2025. doi:10.1200/op.24.00354

BibTeX
@article{Premnath2025,
  author = {Premnath, Naveen and Liu, Yulun and Reves, Heather and Pandey, Urvashi and Nair, Rasmi G and Anderson, Julia and Afrough, Aimaz and Anderson, Larry D and Chung, Stephen S and Kaur, Gurbakhash and Khan, Adeel M and Kumar, Kiran A and Madanat, Yazan F and Wolfe, Heather R and Yilmaz, Elif and Awan, Farrukh T and Sweetenham, John and Ramakrishnan Geethakumari, Praveen},
  title = {Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas},
  journal = {JCO Oncology Practice},
  year = {2025},
  doi = {10.1200/op.24.00354}
}
Kostenlos starten →